---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013415"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-09-15T23:59:59+00:00"
generated_at: "2026-05-17T06:42:06.854260+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs shareholders approve share increase to 1B and equity plans

## Summary
- Shareholders approved increase in authorized common shares from 50M to 1B at Sept 9 special meeting.
- Approved amendments to 2022 equity plan and 2025 equity plan, enabling executive participation.
- Warrants to CEO Ted Karkus and an investor for 500k shares each now fully exercisable.
- Company can now reserve 400% of shares for conversion of July 2025 20% OID notes and warrants.
- Bylaw amendment to update principal office address approved.

## SEC filing metadata
- accession: 0001493152-25-013415
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315225013415/0001493152-25-013415-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315225013415/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013415
- JSON: https://secwatch.observer/filing/0001493152-25-013415.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013415.txt

## Key facts
- Governance Changes
  ProPhase Labs, Inc.: Updated principal office address to RXR Plaza, Uniondale, New York (effective 2025-09-09).
  - Change: bylaw amendment
  - Effective: 2025-09-09
  source text: stockholders approved an amendment to the Company’s Amended and Restated Bylaws to update the Company’s principal office address to RXR Plaza, Uniondale, New York (Proposal 6).
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315225013415/0001493152-25-013415-index.htm
- Governance Changes
  ProPhase Labs, Inc.: Increased number of authorized shares of common stock from 50,000,000 to 1,000,000,000 (effective 2025-09-09).
  - Change: charter amendment
  - Effective: 2025-09-09
  source text: stockholders also approved Certificate of Amendment to its Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 50,000,000 to 1,000,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315225013415/0001493152-25-013415-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.